2024 Laboratory Reimbursement Trends and What to Expect in 2025
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Though Congress didn’t pass VALID as part of the medical devices user fees bill, there’s still a good chance it will pass before year’s end.
Sentencing has been postponed for one month to explore possible government mishandling of key witness testimony.
What you need to know about the 308-page proposed rule and its potential impact on your lab, along with a basic strategy to implement it.
The problems began in January 2020 when hackers got access to an employee’s email account, compromising clients’ personal data.
The agency recently announced subtle but significant changes to its policies governing review of new lab tests for COVID-19.
Two lab staffing experts weigh in on current trends and what labs need to do to attract and retain talent in today’s environment.
A roundup of key mergers, acquisitions, and strategic asset purchases in the healthcare industry in September.
The Hilden, Germany-based company is extending its genetic testing profile beyond oncology to neurology biomarkers.
The agency recently stated that current testing capacity is adequate and established limits on its review of new EUA submissions.
ACLA and public health experts warn that current reimbursement rates will hamper US efforts to contain monkeypox spread.